Literature DB >> 25190753

Proteasome: target for acute and chronic GVHD?

John M Magenau1, Pavan Reddy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25190753      PMCID： PMC4155267          DOI： 10.1182/blood-2014-07-589309

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

Authors:  Mathangi Srinivasan; Ryan Flynn; Andrew Price; Ann Ranger; Jeffrey L Browning; Patricia A Taylor; Jerome Ritz; Joseph H Antin; William J Murphy; Leo Luznik; Mark J Shlomchik; Angela Panoskaltsis-Mortari; Bruce R Blazar
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

2.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  Neddylation plays an important role in the regulation of murine and human dendritic cell function.

Authors:  Nathan Mathewson; Tomomi Toubai; Steven Kapeles; Yaping Sun; Katherine Oravecz-Wilson; Hiroya Tamaki; Ying Wang; Guoqing Hou; Yi Sun; Pavan Reddy
Journal:  Blood       Date:  2013-07-17       Impact factor: 22.113

4.  Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

Authors:  Kai Sun; Lisbeth A Welniak; Angela Panoskaltsis-Mortari; Matthew J O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S Serody; Bruce R Blazar; Thomas J Sayers; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

5.  A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.

Authors:  Alex F Herrera; Haesook T Kim; Bhavjot Bindra; Kyle T Jones; Edwin P Alyea; Philippe Armand; Corey S Cutler; Vincent T Ho; Sarah Nikiforow; Bruce R Blazar; Jerome Ritz; Joseph H Antin; Robert J Soiffer; John Koreth
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-10       Impact factor: 5.742

6.  Treatment of chronic graft-versus-host disease with bortezomib.

Authors:  Chien-Chun Steven Pai; Mingyi Chen; Annie Mirsoian; Steven K Grossenbacher; Joseph Tellez; Erik Ames; Kai Sun; Jared Jagdeo; Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Blood       Date:  2014-07-09       Impact factor: 22.113

7.  Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.

Authors:  Silvia Svegliati; Attilio Olivieri; Nadia Campelli; Michele Luchetti; Antonella Poloni; Silvia Trappolini; Gianluca Moroncini; Andrea Bacigalupo; Pietro Leoni; Enrico V Avvedimento; Armando Gabrielli
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

8.  Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.

Authors:  John Koreth; Kristen E Stevenson; Haesook T Kim; Sean M McDonough; Bhavjot Bindra; Philippe Armand; Vincent T Ho; Corey Cutler; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Jerome Ritz; Edwin P Alyea
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

9.  Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.

Authors:  Ryan Flynn; Jing Du; Rachelle G Veenstra; Dawn K Reichenbach; Angela Panoskaltsis-Mortari; Patricia A Taylor; Gordon J Freeman; Jonathan S Serody; William J Murphy; David H Munn; Stefanie Sarantopoulos; Leo Luznik; Ivan Maillard; John Koreth; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Jason A Dubovsky; John C Byrd; Kelli P MacDonald; Geoff R Hill; Bruce R Blazar
Journal:  Blood       Date:  2014-05-12       Impact factor: 22.113

10.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey S Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113
  10 in total
  1 in total

1.  Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.

Authors:  Victor Tkachev; James Kaminski; E Lake Potter; Scott N Furlan; Alison Yu; Daniel J Hunt; Connor McGuckin; Hengqi Zheng; Lucrezia Colonna; Ulrike Gerdemann; Judith Carlson; Michelle Hoffman; Joe Olvera; Chris English; Audrey Baldessari; Angela Panoskaltsis-Mortari; Benjamin Watkins; Muna Qayed; Yvonne Suessmuth; Kayla Betz; Brandi Bratrude; Amelia Langston; John T Horan; Jose Ordovas-Montanes; Alex K Shalek; Bruce R Blazar; Mario Roederer; Leslie S Kean
Journal:  Sci Transl Med       Date:  2021-01-13       Impact factor: 19.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.